Text Size

A A A

Search


 

 

Photo of doctorsControversies in Stroke Care

Redefining Exclusion/Inclusion Criteria
for IV tPA Use

Original Event: Jun. 20, 2012
For informational purposes only. Accreditation for this program has expired.

View complete overview and accreditation requirements

Download the slides from this webinar (pdf). In order to view these slides, you need to have Adobe Reader installed on your computer (download Adobe Reader).

View additional questions answered by the faculty post-recording.

Other On-demand Accredited Webinars in This Series

Rehabilitation for Stroke Patients, Original program: Jan. 23, 2013
Acute Interventions, Original program: Feb. 28, 2013

This activity is jointly sponsored by Medical Education Resources and National Stroke Association.

Agenda

Redefining Exclusion/Inclusion Criteria for IV tPA Use will address use of IV tPA in the following situations:

  • Mild or rapidly improving symptoms
  • Anticoagulants
  • Seizures

Learning Objectives

Through participation in this activity, participants should be better able to:

  • Discuss the history and background of NINDS’ tPA study criteria
  • Evaluate their respective hospital’s protocol for using IV tPA in acute ischemic stroke
  • Describe a rationale for modifying current IV tPA treatment protocols

Target Audience

The target audience for this activity are neurologists, neuroscience nurses, emergency department physicians and nurses, and hospitalists.

Faculty

Mark J. Alberts, MD
Professor of Neurology
Chief of the Division of Stroke and Cerebrovascular Disease Northwestern University
Feinberg School of Medicine 
Director of the Stroke Program Northwestern Memorial Hospital in Chicago, IL

James C. Grotta, MD
Director, Vascular Neurology Program
Professor and Chairman, Department of Neurology
Roy M. and Phyllis Gough Huffington Distinguished Chair UTHealth Medical School

Arthur Pancioli, MD
Professor and Chairman of the Department of Emergency Medicine University of Cincinnati

Disclosure of Conflicts of Interest
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a CME activity conforms to the generally accepted standards of experimental design, data collection and analysis. MER is committed to providing its learners with high-quality CME activities that promote improvements or quality in health care and not the business interest of a commercial interest.

Faculty Disclosures
The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this CME activity:

Name of Faculty
Dr. Mark J. Alberts
Dr. James C. Grotta
Dr. Arthur Pancioli

Reported Financial Relationship
Consultant and speaker for Genentech
Grant/research support from Lundbeck
Consultant for Banyan International (Advisory Committee)

The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this CME activity:

Name of Content Manager
Denise Henasey, National Stroke Association
Victoria C. Smith, MD, MER
Veronda Smith, FNP-BC, MER

Reported Financial Relationship
No financial relationships to disclose
No financial relationships to disclose
No financial relationships to disclose

Disclaimer

The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, National Stroke Association, and/or Genentech and Penumbra. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Medical Education Resources, National Stroke Association and/or Genentech and Penumbra.  MER’s ANCC accreditation status does not imply endorsement by MER or ANCC of any commercial products displayed in conjunction with this activity. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

System requirements:
PC-based attendees—Required: Windows® 2000, XP Home, XP Pro, 2003 Server, Vista or newer.

Macintosh®-based attendees—Required: Mac OS X 10.4 (Tiger®) or newer.

To view MER’s Privacy Policy: http://www.mer.org/privacy_policy

Controversies in Stroke Care Webinar Series

For informational purposes only. Accreditation for this program has expired.

View complete overview and accreditation requirements Redefining Inclusion/Exclusion Criteria for IV tPA Use
View complete overview and accreditation requirements Rehabilitation for Stroke Patients
View this archived webinar Acute Interventions

If you have questions about this program, contact Valerie Siebert-Thomas at vsiebert-thomas@stroke.org.

Back to Top

The Controversies in Stroke Care webinar series is brought to you by an educational grant from Genentech, Inc. and Penumbra, Inc.

Get Involved

Stroke and You

National Stroke Association

1-800-STROKES
1-800-787-6537
9707 E. Easter Lane, Suite B
Centennial, CO 80112
info@stroke.org